In 2022 the CRE RESPOND Education team shared research and knowledge in an effort to expand our audience and worked to make a real difference in patient outcomes worldwide. Our thanks to sponsors Pfizer, MSD, Gilead and Baxter Compounding who partnered with us in this endeavour.
We offer sponsorship opportunities to industry collaborators every year including the options for capacity building in antimicrobial stewardship, design of clinical studies and design of better drug dosing regimens in Australia and the Asia-Pacific region.
CRE RESPOND consistently attracts world-leading experts to deliver relevant and up-to-date knowledge in a format that is applicable to a broad audience of practitioners. In 2021 we delivered 11 seminars online and in-person, attracting 2333 registrations from 40 countries and added 50 recordings to our library of 158 YouTube videos which are freely available worldwide to support clinicians (9k views in 2021). In 2022 we planned and delivered a further eight hybrid education seminars, symposiums and workshops. We continue to see strong interest from the health community in these programs and have added a further 23 educational videos, with a further six expected by the end of the year on the topics of respiratory and viral infections, and how to dose antimicrobials during RRT and ECMO.
CRE RESPOND is dedicated to ensuring optimal antibiotic use and is confident that the informative events delivered in 2021 - 2022, and planned for 2023 will continue our momentum towards achieving this goal.
On average, the OPAT/HITH Masterclass webinars regularly achieve 195 registrations from invitations sent to the CRE RESPOND subscription list. Participants attend from across Australia, Malaysia, New Zealand, the United States of America, the United Kingdom, Europe, Indonesia, Korea and beyond.
The COVID-19 Therapeutics Whirlwind webinar held in February 2021 received 390 registrations from 31 different countries, including academic researchers, infectious disease physicians, microbiologists, pharmacists, clinicians and registrars, scientists, nurses, among other health professionals.
The Sepsis Diagnosis and Optimisation of Antimicrobials webinar received 396 registrations and the Debate on Precision Dosing – Is it worth the effort? achieved 320 registrations, people dialling in from 30 different countries.
Contact Professor Jason Roberts j.roberts2@uq.edu.au or Luminita Vlad l.vlad@uq.edu.au to request a copy of the 2023 sponsorship prospectus and webinar topics.